Latest News about BIIB
Recent news which mentions BIIB
From Benzinga
From Benzinga
With All Eyes On Lecanemab Read Out In Alzheimer's, Uncertainty Overshadows Biogen's Q2 Beat
July 21, 2022
Tickers
BIIB
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial
July 21, 2022
From Benzinga
Stranger Things Do Happen As Netflix Surprises Investors
July 20, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Beat, Increased FY22 Outlook, Rising Biosimilar Competition: Biogen's Q2 Highlights
July 20, 2022
Tickers
BIIB
From Benzinga
Short-term pain for long-term gains. Investors need to settle in for the long haul, says Bernstein.
July 20, 2022
From MarketWatch
Earnings Scheduled For July 20, 2022
July 20, 2022
From Benzinga
From Benzinga
Bank Of America And Goldman Sachs Split On Earnings Reports, Possibly Putting Bank Rally In Jeopardy
July 18, 2022
From Benzinga
Tesla, Twitter, Goldman Among Headline Earnings Of Unfolding Week: Here Are The Key Earnings Ahead
July 17, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 15, 2022
From Benzinga
Another Way To Understand Market Momentum
July 15, 2022
From Benzinga
From Benzinga
The Fed's Pickle: Whether to Raise Rates to Fight Inflation While Increasing Recession Chances
July 13, 2022
From Benzinga
Stock Split Watch: Could Regeneron Be Next?
July 11, 2022
From Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.